Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Clinical trial NCT00002754 · COMPLETED

Trial details

NCT number: NCT00002754
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Melanoma (Skin)Metastatic Cancer

Start date: 1993-02-01
Primary completion: 2001-04-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.